Fundz

Bostongene Announces $150 Million Series B Funding At A Multi-Billion Dollar Valuation, Propelling The Company To Unicorn Status

PRIVATEApr 06, 2022

Amount Raised

$150 Million

Round Type

Series B

WalthamBiotechnologyHealth Care

Description

BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industrial Partners. The capital will be used to scale BostonGene’s growth, including continued innovation, clinical and research partnerships, and international expansion. Further, leveraging NEC’s robust infrastructure, BostonGene and NEC intend to form a joint venture to bring lifesaving solutions to patients in Japan and other Asian countries.

Quick answer

BostonGene raised $150 Million in a Series B round, dated April 6, 2022. BostonGene is based in Waltham, Massachusetts, United States.

How much did BostonGene raise?
BostonGene raised $150 Million in a Series B round on April 6, 2022.
What does BostonGene do?
BostonGene is a biotechnology company specializing in advanced computational biology and precision medicine.
Where is BostonGene based and how big is it?
BostonGene is based in Waltham, Massachusetts, United States. Fundz records about 501 employees.
Who are the decision-makers at BostonGene?
Fundz holds 1 contact at BostonGene. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as BostonGene that raised within 45 days of this round, from Fundz verified event records.

  • Nuo Therapeutics raised $408K (Seed) on May 19, 2022.
  • Inceptor Bio raised $37M (Series A) on May 19, 2022.
  • Vyriad raised $30M (Series B) on May 17, 2022.
  • WaveFront Dynamics Inc. raised $1.2M (Seed) on May 17, 2022.
  • Impulse Dynamics raised $101M (Funding Round) on May 12, 2022.
  • GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.

Who to call at BostonGene, and when

A new round usually means BostonGene is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BostonGene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BostonGene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BostonGene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BostonGene

Location

Waltham, Massachusetts, United States

About

BostonGene is a biotechnology company specializing in advanced computational biology and precision medicine. Founded in 2015, BostonGene has consistently pushed the boundaries of innovation to improve patient care and accelerate drug development. Our AI-powered multiomics platform decodes cancer patients' molecular profiles, including their immune system and tumor microenvironment, to uncover key disease drivers, identify novel drug targets and recommend the most effective treatments. With advanced bioanalytics, an indication-specific cancer library and a next-generation CLIA-certified, CAP-accredited high-complexity laboratory, we deliver precise, clinically validated insights that drive precision medicine and advance oncology research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BostonGene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for BostonGene's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

BostonGene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.